Snoasis Medical
Snoasis Medical, founded in 2007 and based in Golden, Colorado, develops allograft and xenograft biologics — including BioXclude, ADM, AlloBind, and sutures — for dental surgeons, distributed via the Solvita-owned Maxxeus platform.
- Company typePrivate
- Founded2007
- HeadquartersGolden, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Snoasis Medical firmographics
Firmographics- Name
- Snoasis Medical
- Legal name
- Snoasis Medical
- Website
- https://snoasismedical.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Snoasis Medical, founded in 2007 and based in Golden, Colorado, develops allograft and xenograft biologics — including BioXclude, ADM, AlloBind, and sutures — for dental surgeons, distributed via the Solvita-owned Maxxeus platform.
- Ownership category
- akta.pro rank
Snoasis Medical industry classification
Industry- Product category
- Dental Biologics
- NAICS
- Dental Equipment and Supplies Manufacturing (339114)
- SIC
- Dental Equipment & Supplies (3843)
- akta.pro primary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
Keywords
Where Snoasis Medical is headquartered
LocationHeadquarters
- HQ city
- Golden
- HQ country
- United States
- HQ region
- North America
Markets served
Snoasis Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Biologics Product Sales: Sale of allograft and xenograft biological products for wound care and dental procedures. Products are sold directly through the Maxxeus platform and at trade events.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Snoasis Medical product offering
Product offeringCore offering
Snoasis Medical develops and commercializes regenerative tissue and medical device products—including allografts (human-derived) and xenografts (animal-derived)—for dental surgery and wound care applications. Its portfolio spans branded lines such as BioXclude, ADM (Allograft Dermal Matrix), AlloBind Dappen Dish, and dental sutures, which are marketed and ordered through the Maxxeus dental platform (a Solvita brand).
Differentiator
Problem solved
Functional benefit
Products and services
- BioXclude Allograft (human-derived tissue) membrane product line for dental surgical applications, distributed to dental professionals through the Maxxeus dental platform.
- ADM (Allograft Dermal Matrix) Allograft Dermal Matrix product for dental soft-tissue regeneration applications, sold to dental practitioners via the Maxxeus platform.
- Dental Sutures
Companies that use Snoasis Medical
Customer profileSegments2 records
Ideal customer profiles1 record
Snoasis Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Snoasis Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SolvitacoreSnoasis Medical is a brand under Solvita. The company's biologics products including Snoasis are marketed through the Maxxeus dental platform, which is a brand of Solvita. This represents a parent-subsidiary relationship within the Solvita organization.
Scale indicators1 record
Snoasis Medical competitors and assessment
Company assessmentDirect peers
- Geistlich Pharma: Geistlich is the global leader in dental bone regeneration (Bio-Oss, Bio-Gide), offering xenograft and membrane products directly comparable to Snoasis's allograft and xenograft portfolio for dental surgical use.
- ZimVie (Biomet 3i): ZimVie offers RegenerOss dental bone graft substitutes and regenerative products, competing directly with Snoasis in the dental allograft and xenograft category.
- LifeNet Health: LifeNet Health is a major allograft tissue processor serving dental and orthopedic regenerative applications, with overlapping product formats and clinician customers to Snoasis.
- RTI Surgical: RTI Surgical produces allograft and xenograft biologics for dental, spine, and surgical use, with a comparable tissue-based regenerative product portfolio to Snoasis.
- Osteogenics Biomedical: Osteogenics specializes in dental regenerative products including bone graft substitutes and barrier membranes, serving the same periodontist and oral surgeon customer base as Snoasis.
- BioHorizons (Henry Schein): BioHorizons offers dental implant systems bundled with regenerative products (allografts, xenografts, membranes) and serves the same implant-focused dental professionals as Snoasis.
Broad incumbents
- Straumann Group: Straumann is a global dental implant leader with a regenerative portfolio (XenoFlex, botiss biologics) that competes with Snoasis while offering a much broader implant and digital dentistry ecosystem.
- Dentsply Sirona: Dentsply Sirona is a broad dental equipment and consumables incumbent that includes regenerative and membrane products alongside its dominant chairside, imaging, and implant lines.
- Integra LifeSciences: Integra LifeSciences is a diversified regenerative tissue and medical device company with dental and wound care biologics lines that overlap with Snoasis's product categories.
Emerging players
- Botiss biomaterials: Botiss (now part of Straumann) is a European specialist in dental bone and soft-tissue regeneration with xenografts, allografts, and membranes directly comparable to Snoasis's portfolio.
Market position
Customer concentration
Snoasis Medical social profiles
Digital presenceSnoasis Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Snoasis Medical leadership team
Management profileNumber of profiles
Profiles4 records
Snoasis Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Snoasis Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Snoasis Medical
What does Snoasis Medical do?
Snoasis Medical develops and commercializes regenerative tissue and medical device products—including allografts (human-derived) and xenografts (animal-derived)—for dental surgery and wound care applications. Its portfolio spans branded lines such as BioXclude, ADM (Allograft Dermal Matrix), AlloBind Dappen Dish, and dental sutures, which are marketed and ordered through the Maxxeus dental platform (a Solvita brand).
Is Snoasis Medical a public or private company?
Snoasis Medical is a private company. It is classified as corporate owned and is currently operating.
When was Snoasis Medical founded?
Snoasis Medical was founded in 2007. It employs 11 to 50 people.
Where is Snoasis Medical based?
Snoasis Medical is headquartered in Golden, United States, in the North America region.
How does Snoasis Medical make money?
One revenue line is on record: biologics Product Sales.
Who are Snoasis Medical's main competitors?
Direct peers on record are Geistlich Pharma, ZimVie (Biomet 3i), LifeNet Health, RTI Surgical, Osteogenics Biomedical and BioHorizons (Henry Schein). Broad incumbents are Straumann Group, Dentsply Sirona and Integra LifeSciences. Botiss biomaterials is listed as an emerging player.
Does Snoasis Medical have an API?
No public API is recorded for Snoasis Medical.
What industry is Snoasis Medical in?
Snoasis Medical's product category is Dental Biologics. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM). Its NAICS code is 339114 and its SIC code is 3843.